CN Stock MarketDetailed Quotes

603079 Zhejiang Shengda Bio-Pharm

Watchlist
  • 15.02
  • -0.26-1.70%
Not Open Nov 28 15:00 CST
2.57BMarket Cap-89404P/E (TTM)

Zhejiang Shengda Bio-Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
11.90%608.87M
5.91%384.47M
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
Operating revenue
11.90%608.87M
5.91%384.47M
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
Other operating revenue
----
-53.47%476.6K
----
82.81%1.94M
----
10.67%1.02M
----
-13.42%1.06M
----
41.46%925.62K
Total operating cost
6.90%577.39M
0.97%364.48M
5.56%177.35M
3.00%729.02M
8.15%540.12M
12.91%360.97M
0.48%168.01M
-3.13%707.79M
-4.83%499.43M
-9.14%319.7M
Operating cost
8.33%485.92M
2.52%307.57M
7.39%147.71M
0.62%610.95M
8.92%448.56M
15.37%300M
2.26%137.55M
8.18%607.17M
0.14%411.83M
-6.28%260.04M
Operating tax surcharges
8.76%7.43M
14.94%4.78M
50.18%2.25M
9.11%9.41M
19.40%6.83M
23.64%4.16M
-32.00%1.5M
-21.69%8.63M
-9.79%5.72M
-11.95%3.36M
Operating expense
4.03%10.09M
-2.40%6.48M
-7.39%2.77M
7.19%14.2M
-5.55%9.7M
2.54%6.64M
5.73%2.99M
6.24%13.25M
44.44%10.27M
49.17%6.48M
Administration expense
-6.88%49.67M
-9.58%32.22M
1.43%17.75M
-1.96%61.96M
-19.88%53.34M
-13.90%35.63M
-1.23%17.5M
-35.11%63.2M
-2.23%66.58M
-0.59%41.39M
Financial expense
44.13%-4.75M
19.49%-5.38M
-42.32%-1.03M
52.31%-10.44M
63.36%-8.5M
41.57%-6.68M
-126.25%-721.61K
-346.76%-21.88M
-688.39%-23.19M
-325.55%-11.43M
-Interest expense (Financial expense)
16.01%1.1M
105.03%848.17K
279.23%573.62K
-66.28%1.54M
-79.46%948.16K
-85.45%413.68K
-91.28%151.26K
-20.84%4.56M
6.87%4.62M
-7.48%2.84M
-Interest Income (Financial expense)
22.93%-4.11M
9.69%-3.18M
38.06%-1.27M
-110.92%-8.41M
-41.82%-5.33M
-335.97%-3.52M
-411.12%-2.05M
-35.83%-3.99M
11.65%-3.76M
69.55%-807.53K
Research and development
-3.84%29.03M
-11.35%18.81M
-14.09%7.9M
14.72%42.92M
6.96%30.19M
6.81%21.22M
27.74%9.19M
-5.61%37.42M
0.65%28.22M
1.72%19.86M
Credit Impairment Loss
-493.85%-6.66M
-154.83%-4.3M
-182.25%-856.53K
-592.56%-3.16M
-608.89%-1.12M
-199.50%-1.69M
80.66%-303.46K
49.07%-456.39K
88.71%-158.09K
56.24%-562.81K
Asset Impairment Loss
-23.58%-5.97M
-12.11%-5.91M
---2.71M
-182.91%-50.81M
23.27%-4.83M
-2.53%-5.27M
----
-174.38%-17.96M
17.26%-6.3M
-23.72%-5.14M
Other net revenue
-251.38%-3.26M
-119.33%-2.64M
-99.43%26.38K
-844.91%-44.06M
-87.43%2.15M
-108.04%-1.2M
-17.25%4.61M
-73.57%5.92M
18.89%17.14M
27.99%14.97M
Fair value change income
-92.83%2.07K
-93.67%1.11K
----
100.01%100.88
300.18%28.84K
221.61%17.52K
----
-6,325.82%-897.06K
95.82%-14.41K
97.34%-14.41K
Invest income
310.03%3.02M
332.62%2.93M
149.72%1.69M
-96.40%406.51K
-93.12%735.39K
-93.55%677.25K
-69.26%677.25K
-47.58%11.29M
-33.38%10.69M
-9.89%10.5M
Asset deal income
----
----
----
132.20%202.17K
206.32%301.71K
252.88%301.71K
----
6,489.49%87.07K
7,354.35%98.5K
--85.5K
Other revenue
-9.81%6.35M
-2.58%4.64M
-55.11%1.9M
-32.87%9.3M
-45.08%7.04M
-52.92%4.76M
-15.55%4.24M
67.44%13.85M
65.92%12.82M
67.62%10.11M
Operating profit
359.65%28.22M
1,935.37%17.35M
27.70%7.51M
-226.35%-45.68M
-88.55%6.14M
-98.14%852.5K
-75.02%5.88M
-55.61%36.15M
-22.68%53.62M
-8.55%45.71M
Add:Non operating Income
1,658.59%11.17M
3,569.41%11.02M
-85.91%65.9K
213.65%2.99M
-17.66%635.2K
-40.69%300.23K
218.73%467.68K
93.14%953.47K
65.50%771.43K
75.11%506.19K
Less:Non operating expense
144.38%4.19M
280.12%4.18M
-99.65%2.66K
353.26%2.62M
336.05%1.71M
327.45%1.1M
54,783.87%769.57K
-69.49%578.54K
-84.52%392.99K
322.30%256.96K
Total profit
595.52%35.21M
44,395.29%24.19M
35.75%7.57M
-224.05%-45.31M
-90.63%5.06M
-99.88%54.37K
-76.45%5.58M
-54.37%36.52M
-19.74%54M
-8.47%45.96M
Less:Income tax cost
1.42%7.8M
-22.76%4.71M
-1.69%2.26M
46.16%8.89M
-15.02%7.69M
-10.27%6.1M
-29.79%2.3M
-25.97%6.09M
19.76%9.05M
48.37%6.8M
Net profit
1,143.49%27.41M
421.96%19.48M
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
Net profit from continuing operation
1,143.49%27.41M
421.96%19.48M
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
Less:Minority Profit
440.02%5.73M
953.65%2.98M
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
Net profit of parent company owners
687.86%21.68M
360.46%16.49M
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
Earning per share
Basic earning per share
750.00%0.13
350.00%0.1
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
Diluted earning per share
750.00%0.13
350.00%0.1
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
Other composite income
Total composite income
1,143.49%27.41M
421.96%19.48M
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
Total composite income of parent company owners
687.86%21.68M
360.46%16.49M
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
Total composite income of minority owners
440.02%5.73M
953.65%2.98M
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 11.90%608.87M5.91%384.47M9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M
Operating revenue 11.90%608.87M5.91%384.47M9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M
Other operating revenue -----53.47%476.6K----82.81%1.94M----10.67%1.02M-----13.42%1.06M----41.46%925.62K
Total operating cost 6.90%577.39M0.97%364.48M5.56%177.35M3.00%729.02M8.15%540.12M12.91%360.97M0.48%168.01M-3.13%707.79M-4.83%499.43M-9.14%319.7M
Operating cost 8.33%485.92M2.52%307.57M7.39%147.71M0.62%610.95M8.92%448.56M15.37%300M2.26%137.55M8.18%607.17M0.14%411.83M-6.28%260.04M
Operating tax surcharges 8.76%7.43M14.94%4.78M50.18%2.25M9.11%9.41M19.40%6.83M23.64%4.16M-32.00%1.5M-21.69%8.63M-9.79%5.72M-11.95%3.36M
Operating expense 4.03%10.09M-2.40%6.48M-7.39%2.77M7.19%14.2M-5.55%9.7M2.54%6.64M5.73%2.99M6.24%13.25M44.44%10.27M49.17%6.48M
Administration expense -6.88%49.67M-9.58%32.22M1.43%17.75M-1.96%61.96M-19.88%53.34M-13.90%35.63M-1.23%17.5M-35.11%63.2M-2.23%66.58M-0.59%41.39M
Financial expense 44.13%-4.75M19.49%-5.38M-42.32%-1.03M52.31%-10.44M63.36%-8.5M41.57%-6.68M-126.25%-721.61K-346.76%-21.88M-688.39%-23.19M-325.55%-11.43M
-Interest expense (Financial expense) 16.01%1.1M105.03%848.17K279.23%573.62K-66.28%1.54M-79.46%948.16K-85.45%413.68K-91.28%151.26K-20.84%4.56M6.87%4.62M-7.48%2.84M
-Interest Income (Financial expense) 22.93%-4.11M9.69%-3.18M38.06%-1.27M-110.92%-8.41M-41.82%-5.33M-335.97%-3.52M-411.12%-2.05M-35.83%-3.99M11.65%-3.76M69.55%-807.53K
Research and development -3.84%29.03M-11.35%18.81M-14.09%7.9M14.72%42.92M6.96%30.19M6.81%21.22M27.74%9.19M-5.61%37.42M0.65%28.22M1.72%19.86M
Credit Impairment Loss -493.85%-6.66M-154.83%-4.3M-182.25%-856.53K-592.56%-3.16M-608.89%-1.12M-199.50%-1.69M80.66%-303.46K49.07%-456.39K88.71%-158.09K56.24%-562.81K
Asset Impairment Loss -23.58%-5.97M-12.11%-5.91M---2.71M-182.91%-50.81M23.27%-4.83M-2.53%-5.27M-----174.38%-17.96M17.26%-6.3M-23.72%-5.14M
Other net revenue -251.38%-3.26M-119.33%-2.64M-99.43%26.38K-844.91%-44.06M-87.43%2.15M-108.04%-1.2M-17.25%4.61M-73.57%5.92M18.89%17.14M27.99%14.97M
Fair value change income -92.83%2.07K-93.67%1.11K----100.01%100.88300.18%28.84K221.61%17.52K-----6,325.82%-897.06K95.82%-14.41K97.34%-14.41K
Invest income 310.03%3.02M332.62%2.93M149.72%1.69M-96.40%406.51K-93.12%735.39K-93.55%677.25K-69.26%677.25K-47.58%11.29M-33.38%10.69M-9.89%10.5M
Asset deal income ------------132.20%202.17K206.32%301.71K252.88%301.71K----6,489.49%87.07K7,354.35%98.5K--85.5K
Other revenue -9.81%6.35M-2.58%4.64M-55.11%1.9M-32.87%9.3M-45.08%7.04M-52.92%4.76M-15.55%4.24M67.44%13.85M65.92%12.82M67.62%10.11M
Operating profit 359.65%28.22M1,935.37%17.35M27.70%7.51M-226.35%-45.68M-88.55%6.14M-98.14%852.5K-75.02%5.88M-55.61%36.15M-22.68%53.62M-8.55%45.71M
Add:Non operating Income 1,658.59%11.17M3,569.41%11.02M-85.91%65.9K213.65%2.99M-17.66%635.2K-40.69%300.23K218.73%467.68K93.14%953.47K65.50%771.43K75.11%506.19K
Less:Non operating expense 144.38%4.19M280.12%4.18M-99.65%2.66K353.26%2.62M336.05%1.71M327.45%1.1M54,783.87%769.57K-69.49%578.54K-84.52%392.99K322.30%256.96K
Total profit 595.52%35.21M44,395.29%24.19M35.75%7.57M-224.05%-45.31M-90.63%5.06M-99.88%54.37K-76.45%5.58M-54.37%36.52M-19.74%54M-8.47%45.96M
Less:Income tax cost 1.42%7.8M-22.76%4.71M-1.69%2.26M46.16%8.89M-15.02%7.69M-10.27%6.1M-29.79%2.3M-25.97%6.09M19.76%9.05M48.37%6.8M
Net profit 1,143.49%27.41M421.96%19.48M62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M
Net profit from continuing operation 1,143.49%27.41M421.96%19.48M62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M
Less:Minority Profit 440.02%5.73M953.65%2.98M779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K
Net profit of parent company owners 687.86%21.68M360.46%16.49M9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M
Earning per share
Basic earning per share 750.00%0.13350.00%0.10.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23
Diluted earning per share 750.00%0.13350.00%0.10.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23
Other composite income
Total composite income 1,143.49%27.41M421.96%19.48M62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M
Total composite income of parent company owners 687.86%21.68M360.46%16.49M9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M
Total composite income of minority owners 440.02%5.73M953.65%2.98M779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data